Biocefa 50 mg tabletten voor honden en katten
Biocefa 50 mg tabletten voor honden en katten
Authorised
- Cefalexin
Product identification
Medicine name:
Biocefa 50 mg tabletten voor honden en katten
Active substance:
- Cefalexin
Target species:
-
Dog
-
Cat
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Cefalexin50.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01DB01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Netherlands
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Informed consent application (Article 13c of Directive No 2001/82/EC)
Marketing authorisation holder:
- Axience
Marketing authorisation date:
Manufacturing sites for batch release:
- Lelypharma B.V.
Responsible authority:
- Medicines Evaluation Board
Authorisation number:
- REG NL 129157
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Dutch (PDF)
Published on: 17/04/2023
